WeightWatchers Adds Telehealth & Obesity Meds
March 7, 2023 — Okay, we’re awake now. WeightWatchers has entered a deal to add telehealth and obesity meds to their business strategy. The company will spend $132 million in cash and stock to acquire Sequence – a subscription telehealth service for weight loss that utilizes advanced obesity meds like semaglutide. Weight Watchers CEO Sima Sistani explains her rationale […]